Order Article Reprints

Shibata T, Cao D-Y, Dar TB, Ahmed F, Bhat SA, Veiras LC, Bernstein EA, Khan AA, Chaum M, Shiao SL, et al. miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC. Cancers. 2022; 14(21):5273. https://doi.org/10.3390/cancers14215273

Shibata, Tomohiro, Duo-Yao Cao, Tahir B. Dar, Faizan Ahmed, Shabir A. Bhat, Luciana C. Veiras, Ellen A. Bernstein, Abdul Arif Khan, Manita Chaum, Stephen L. Shiao, and et al. 2022. "miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC" Cancers 14, no. 21: 5273. https://doi.org/10.3390/cancers14215273

Shibata, T., Cao, D.-Y., Dar, T. B., Ahmed, F., Bhat, S. A., Veiras, L. C., Bernstein, E. A., Khan, A. A., Chaum, M., Shiao, S. L., Tourtellotte, W. G., Giani, J. F., Bernstein, K. E., Cui, X., Vail, E., & Khan, Z. (2022). miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC. Cancers, 14(21), 5273. https://doi.org/10.3390/cancers14215273